Concepedia

Publication | Closed Access

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.

DOI

82

Citations

13

References

2005

Year

Steven R. Schwid, John Thorpe, Mohammad K. Sharief, Magnhild Sandberg‐Wollheim, Kottil Rammohan, Jeanette Wendt, Hillel Panitch, Douglas S. Goodin, David Li, Peter Chang,
PubMed

Abstract

Patients receiving interferon beta-1a improved on clinical and MRI disease measures when they changed from 30 microg QW to 44 microg TIW.

References

YearCitations

Page 1